Geoff Oxnard, MD


Thoracic Oncologist, Dana-Farber Cancer Institute, and Associate Professor of Medicine, Harvard Medical School, Boston, MA

Authored Items

Best Practices: Evolving Understanding of Molecular Diagnostics and Biomarkers in Lung Cancer

September 2018, Vol 8, No 9 - 2018 ASCO, Interview with the Innovators

At ASCO 2018, Oncology Practice Management (OPM) discussed the current state of genetics and genomic testing, the increasing understanding of biomarkers, and how they influence the treatment of patients with lung cancer. The discussion highlighted the interaction between oncologists and pathologists to facilitate best outcomes for patients. This interview included Lauren Ritterhouse, MD, PhD, Co-Director, Clinical Genomics Lab, University of Chicago, IL, and Geoff Oxnard, MD, Thoracic Oncologist, Dana-Farber Cancer Institute, and Associate Professor of Medicine, Harvard Medical School, Boston, MA. [ Read More ]